The introduction of anti-VEGF agents has revolutionized the field of medical retina care by reducing rates of vision loss and ...

Celltrion today announced that the European Commission (EC) has granted marketing authorization for three products across two ...

Telomir Pharmaceuticals (NASDAQ: TELO) announced positive preclinical results demonstrating its lead compound, Telomir-1, significantly reduced react ...

D Molecular Therapeutics is undervalued, with its lead candidate 4D-150 showing potential. Click here to find out why I rate ...

So far, five biosimilars that reference Eylea 2 mg have been approved by the FDA. Alvotech/Teva expect to regulatory approval ...

Presidents' Day is officially behind us and while most of Monday's epic deals have expired, I've spotted a handful of sales you can still get. There's no guarantee these deals will last through the ...

Telomir Pharmaceuticals (TELO) announced results from its recent preclinical studies conducted in human retinal cell lines. These studies ...